Rigetti Computing, Inc. Common Stock
RGTI
$20.64
-9.07%
Rigetti Computing, Inc. is a pure-play quantum computing company that builds superconducting quantum processors and sells integrated quantum computing systems, ranging from 9-qubit to 108-qubit machines, under the Novera and Cepheus trade names. The company operates as a specialized hardware and platform provider in the nascent quantum computing industry, offering access to its systems via its Rigetti Quantum Cloud Services (QCS) platform. The current investor narrative is dominated by a speculative rally fueled by significant U.S. government funding announcements, with recent news highlighting a $100 million direct investment into Rigetti and a broader $2 billion sector bet, which has ignited debate over the commercial viability timeline and the extreme valuations of these pre-revenue, loss-making companies.…
RGTI
Rigetti Computing, Inc. Common Stock
$20.64
Related headlines
Investment Opinion: Should I buy RGTI Today?
Rating: Hold. The core thesis is that RGTI is a purely speculative instrument with binary outcomes, where current extreme valuation and weak fundamentals justify caution, but government funding provides a near-term floor preventing an immediate Sell recommendation.
Supporting evidence for this Hold rating includes the astronomical valuation (PS 968x, EV/Sales 643.6x), which is unsustainable without immediate and massive revenue growth. Revenue is currently contracting at -17.85% YoY, and the company is deeply unprofitable with a -39.58% ROE. While analyst sentiment is bullish, the average revenue estimate of $223 million implies growth of over 11,800% from the last quarterly run-rate, highlighting the sheer magnitude of expectations. The stock's 90% higher volatility than the market (beta 1.902) further underscores its speculative, high-risk nature.
The two biggest risks that could invalidate this thesis are 1) a further deceleration in revenue growth or a failure to show commercial progress from government contracts, and 2) a broader market downturn that crushes speculative, profitless tech stocks. This Hold would upgrade to a Buy only if the company demonstrates consecutive quarters of accelerating revenue growth (e.g., >50% QoQ) and a credible path to gross margin expansion above 50%. It would downgrade to a Sell if the stock fails to hold above the $15 support level or if quarterly cash burn exceeds $25 million without a clear funding runway. Relative to any traditional fundamental benchmark, the stock is severely overvalued. Its value is entirely based on long-dated, high-risk optionality.
Sign up to view all
RGTI 12-Month Price Forecast
The 12-month outlook for RGTI is a coin flip dominated by volatility rather than fundamentals. The base case (50% probability) is a continued holding pattern characterized by high volatility within a $15-$25 range, as government funding prevents a collapse but lack of commercial progress prevents a breakout. The bear case (30%) is more probable than the bull case (20%) given the complete absence of current financial traction. The AI assessment is Neutral with Medium confidence. The stance is predicated on the temporary support from government capital, but would turn Bearish with High confidence if the next two quarterly reports fail to show any revenue acceleration. Conversely, it would turn Bullish only upon seeing evidence that the funding is directly converting into recurring, growing customer contracts.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Rigetti Computing, Inc. Common Stock's 12-month outlook, with a consensus price target around $26.83 and implied upside of +30.0% versus the current price.
Average Target
$26.83
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$17 - $27
Analyst target range
Analyst coverage is limited, with only 3 analysts providing estimates, indicating this is a small-cap, speculative stock with limited institutional following, which can lead to higher volatility and less efficient price discovery. The consensus leans bullish, as evidenced by recent institutional ratings where firms like Benchmark, Rosenblatt, and Mizuho maintain 'Buy' or 'Outperform' ratings, and B. Riley Securities upgraded the stock from 'Neutral' to 'Buy' in January 2026, signaling positive sentiment among the few covering analysts. The target price range is implied by revenue estimates, with a high estimate of $276.1 million and a low of $172.9 million, representing a wide 60% spread that underscores the high uncertainty and lack of visibility into the company's future commercial success; the high target likely assumes successful commercialization and market capture from government funding, while the low target may price in continued operational challenges and cash burn.
Bulls vs Bears: RGTI Investment Factors
The investment debate for Rigetti Computing is a stark clash between speculative narrative and harsh financial reality. The bull case is powered almost entirely by external catalysts—specifically, massive U.S. government funding—and a speculative rally that has driven the stock up 73% over the past year. The bear case is grounded in indisputable fundamentals: declining revenue, massive losses, an extreme cash burn rate, and a valuation that prices in perfection decades ahead. Currently, the bear side holds stronger evidence, as the company's financials show no signs of the commercial progress needed to justify its valuation. The single most important tension is the timeline for commercialization. If Rigetti can rapidly convert government funding into tangible, growing revenue streams, the bull narrative could gain footing. If commercialization remains elusive and cash burn continues, the stock faces a precipitous fall back towards its fundamental value, likely near its 52-week low.
Bullish
- Massive Government Funding Catalyst: A $100 million direct investment from the U.S. government and a broader $2 billion sector bet provide Rigetti with non-dilutive capital and validate its technology roadmap. This funding significantly de-risks the near-term cash burn, evidenced by a TTM free cash flow of -$77.2 million, and accelerates its path to commercialization.
- Extreme Speculative Momentum: The stock has surged 29.75% over the last 3 months and 13.93% over the last month, dramatically outperforming the S&P 500. This powerful rally from the 52-week low of $10.30 indicates a strong speculative bid and a potential shift in market sentiment towards the quantum computing sector.
- Analyst Sentiment Remains Bullish: Despite limited coverage, the few covering analysts maintain 'Buy' or 'Outperform' ratings, with B. Riley Securities upgrading from 'Neutral' to 'Buy' in January 2026. This consensus bullishness, anchored by high revenue estimates of up to $276 million, provides a narrative anchor for the stock's speculative valuation.
- Valuation Below Recent Historical Peak: The current Price-to-Sales ratio of 968x, while astronomically high, is well below its recent historical peak of over 3,673x seen in late 2025. This suggests the market has already priced out some of the most extreme optimism, leaving room for a re-rating if commercial progress materializes.
Bearish
- Extreme Valuation with No Earnings: The stock trades at a trailing PS ratio of 968x and an EV/Sales of 643.6x, representing a pure speculation on a distant future. With a net loss of -$18.2 million last quarter and negative EBITDA, the valuation is completely detached from current fundamentals, creating severe downside risk if growth expectations falter.
- Revenue Declining, No Commercial Traction: Recent quarterly revenue of $1.87 million represents a -17.85% year-over-year decline, and the multi-quarter trend shows revenue falling from $3.05 million in Q1 2024. This deceleration contradicts the narrative of imminent commercialization and highlights the company's pre-revenue, R&D-heavy stage.
- Precarious Financial Health & Cash Burn: The company is burning cash at an alarming rate, with TTM free cash flow of -$77.2 million and a return on equity of -39.58%. Despite a low debt-to-equity ratio of 0.013, it is heavily reliant on external financing (like the recent government funding) to sustain operations, making it vulnerable to any funding interruptions.
- Extreme Volatility and High Beta: With a beta of 1.902, the stock is approximately 90% more volatile than the broader market, as evidenced by its 52-week range from $10.30 to $58.15. This high volatility, coupled with a -77.1% max drawdown, makes it a high-risk instrument unsuitable for risk-averse investors and prone to sharp corrections.
RGTI Technical Analysis
The stock is in a volatile recovery phase from a deep drawdown, with a 1-year price change of +73.39% but a 6-month change of -18.81%, indicating a sharp recent rally from lower levels. The current price of $20.98 sits at approximately 20% of its 52-week range, positioned closer to the 52-week low of $10.30 than the high of $58.15, suggesting the stock is still recovering from a severe downturn and is not yet near overextended territory. Recent momentum has been exceptionally strong, with a 1-month gain of +13.93% and a 3-month surge of +29.75%, significantly outpacing the S&P 500's returns of -0.08% and +12.0% over the same periods, indicating a powerful, speculative-driven short-term rally that diverges from the longer-term downtrend observed in the first half of the 180-day price data. Key technical levels are the 52-week low of $10.30, which now serves as a distant but critical support, and the 52-week high of $58.15, which represents a formidable resistance level requiring a 177% rally from the current price; the stock's beta of 1.902 confirms it is approximately 90% more volatile than the broader market, making it a high-risk, high-volatility instrument where position sizing is crucial.
Beta
1.90
1.90x market volatility
Max Drawdown
-77.1%
Largest decline past year
52-Week Range
$10-$58
Price range past year
Annual Return
+69.7%
Cumulative gain past year
| Period | RGTI Return | S&P 500 |
|---|---|---|
| 1m | +15.6% | +1.5% |
| 3m | +31.7% | +13.4% |
| 6m | -9.6% | +10.9% |
| 1y | +69.7% | +24.5% |
| ytd | -12.5% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RGTI Fundamental Analysis
Revenue is minimal and declining, with the most recent quarterly revenue of $1.868 million representing a year-over-year contraction of -17.85%; the multi-quarter trend shows revenue has fallen from $3.052 million in Q1 2024 to the current level, indicating a significant deceleration and lack of commercial traction. The company is deeply unprofitable, posting a net loss of $18.207 million in Q4 2025 and a gross margin of 34.9%, which, while positive for the quarter, has been highly volatile and negative in prior periods (e.g., -8.6% annual gross margin), demonstrating the company is far from achieving sustainable operations or scale. Financial health is precarious, with a trailing twelve-month free cash flow of -$77.219 million, a return on equity of -39.58%, and a debt-to-equity ratio of 0.013; the company is burning cash at an alarming rate to fund R&D and operations, relying heavily on external financing (evidenced by significant common stock issuance in recent cash flow statements) rather than internal generation.
Quarterly Revenue
$1868000.0B
2025-12
Revenue YoY Growth
-0.17%
YoY Comparison
Gross Margin
+0.34%
Latest Quarter
Free Cash Flow
$-77219000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RGTI Overvalued?
Given the company's negative net income and EBITDA, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is an astronomical 968.0x, while the forward-looking EV/Sales multiple is 643.6x, indicating the market is pricing in massive future revenue growth expectations, though the gap between trailing and forward multiples suggests some anticipated sales expansion. Compared to typical hardware or technology sectors, this valuation represents an extreme premium, reflecting a pure speculation on the future quantum computing market rather than any current fundamentals. Historically, the stock's own PS ratio has been wildly volatile, ranging from as low as 14.7x in late 2022 to over 3,673x in late 2025; the current 968x PS ratio sits well below its recent historical peak but remains near the upper end of its multi-year range, indicating the market is still pricing in highly optimistic, long-dated growth prospects despite recent price declines.
PE
-31.7x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -94x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-32.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and immediate. The company is deeply unprofitable, with a Q4 2025 net loss of $18.2 million on only $1.87 million in revenue, resulting in a net margin of -30.5%. It is burning cash at a rate of -$77.2 million (TTM FCF) to fund R&D, with gross margins volatile and recently at 34.9%. Revenue is not only minimal but declining year-over-year by -17.85%, indicating a complete lack of commercial scale or momentum. The business model is entirely dependent on continued external financing, as internal cash generation is non-existent.
Market & Competitive Risks are amplified by its extreme valuation and nascent industry. Trading at a PS ratio of 968x, the stock is priced for flawless, hyper-growth execution over many years. Any disappointment in the commercial timeline, technological progress, or competitive positioning could trigger catastrophic multiple compression. The beta of 1.902 confirms high sensitivity to market swings and sector rotations away from speculative tech. Recent news highlights the emergence of well-capitalized competitors like Quantinuum via IPO, which could cannibalize market share and government contracts. The entire rally is fueled by government funding news, making the stock highly vulnerable to shifts in political or budgetary priorities.
Worst-Case Scenario involves a failure to achieve technological milestones or secure follow-on funding after the initial government capital is depleted. This could lead to a liquidity crisis, forcing dilutive equity raises or even bankruptcy. In this scenario, the market would rapidly reprice the stock based on its distressed fundamentals, ignoring the long-dated optionality. A realistic downside target is a return to the 52-week low of $10.30, which would represent a loss of approximately -51% from the current price of $20.98. Given the stock's history of a -77.1% max drawdown, a decline of 50-70% is a plausible adverse outcome if the speculative bubble deflates.
FAQ
The key risks are, in order of severity: 1) Valuation & Commercialization Risk: The stock could collapse 50-70% if revenue growth fails to materialize to justify its 968x PS ratio. 2) Financial Risk: The company is burning over $77 million in cash annually and relies entirely on external funding (like the recent $100M government investment) to survive. 3) Competitive & Technological Risk: Well-funded competitors like Quantinuum could outpace Rigetti, rendering its technology obsolete. 4) Volatility Risk: With a beta of 1.9, the stock is prone to wild swings, as seen in its 52-week range from $10.30 to $58.15.
The 12-month forecast is highly uncertain and volatile. Our analysis outlines three scenarios: A Bull Case (20% probability) targeting $40-$58 if commercialization accelerates. A Base Case (50% probability) targeting $15-$25, where the stock churns on news but lacks fundamental drivers. A Bear Case (30% probability) targeting $10-$14, where disappointing progress triggers a return to 52-week lows. The Base Case is most likely, implying the stock may trade sideways to slightly down from its current $20.98 price. The key assumption is that government funding prevents a collapse but does not catalyze near-term hyper-growth.
RGTI is severely overvalued by any conventional fundamental metric. With a Price-to-Sales ratio of 968x and negative earnings, the market is pricing in decades of flawless, hyper-growth that may never materialize. Compared to any established hardware or tech sector, this valuation is an extreme outlier. The stock is not valued on current operations but on the long-dated option value of its technology. This implies the market expects Rigetti to grow its revenue from $1.87 million per quarter to hundreds of millions within a few years—a scenario with very low probability.
RGTI is not a 'good' stock to buy for the vast majority of investors. It is a highly speculative, binary bet on the distant future of quantum computing, characterized by extreme valuation (968x PS ratio), declining revenue (-17.85% YoY), and massive cash burn (-$77M TTM FCF). It could be considered a very high-risk, small-position speculation only for investors who understand the technology, have a 5+ year horizon, and can afford to lose their entire investment. The 51% potential downside to its 52-week low far outweighs the uncertain upside.
RGTI is categorically unsuitable for short-term trading or investment due to its extreme volatility (beta 1.902) and lack of earnings-based catalysts. It is a long-term, speculative investment by nature, as the quantum computing market may take 5-10 years to mature. However, 'long-term' here carries the high risk of permanent capital loss if the company fails. The only appropriate holding period is the very long term (5+ years) for investors willing to treat it as a venture-style bet. There is no dividend, and earnings visibility is zero, eliminating any rationale for income or short-term tactical plays.